Cue Biopharma: Funding, Investors & Team (Oct 2026)
Cue Biopharma is a company that specializes in immunotherapy and is creating biologics that can selectively target disease-related T cells in order to treat cancer and autoimmune conditions. By mimicking the signals given by the body's antigen-presenting cells, Cue's biologics can prompt specific immune responses in the T cells associated with certain diseases. With a strong team of experts in protein biologics, immunology, and immuno-oncology, Cue has developed a range of promising drug candidates and is preparing to bring two leading programs to clinical trials. Based in Cambridge, Massachusetts, Cue is well-positioned to advance the field of immunotherapy.
Cue Biopharma has raised $102M across 5 funding rounds on record, the most recent an undisclosed round of $30.0M announced in Apr 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cue Biopharma Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Cue Biopharma Funding Rounds
Cue Biopharma raised $30.0M in an undisclosed round announced in Nov 2022.
1.8 years later, an undisclosed round of $12.0M was announced in Sep 2024.
7 months later, an undisclosed round of $20.0M was announced in Apr 2025.
8 months later, an undisclosed round of $10.0M was announced in Dec 2025.
4 months later, an undisclosed round of $30.0M was announced in Apr 2026.
Cue Biopharma Founders and Leadership Team
No contact details are on record for this team yet.
Cue Biopharma Funding Compared to Other Biotechnology Startups
Cue Biopharma's latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cue Biopharma in Biotechnology and Cambridge
Companies Similar to Cue Biopharma
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Cue Biopharma Funding FAQs
What does Cue Biopharma do?
Cue Biopharma is a company that specializes in immunotherapy and is creating biologics that can selectively target disease-related T cells in order to treat cancer and autoimmune conditions. By mimicking the signals given by the body's antigen-presenting cells, Cue's biologics can prompt specific immune responses in the T cells associated with certain diseases. With a strong team of experts in protein biologics, immunology, and immuno-oncology, Cue has developed a range of promising drug candidates and is preparing to bring two leading programs to clinical trials. Based in Cambridge, Massachusetts, Cue is well-positioned to advance the field of immunotherapy.
How much funding has Cue Biopharma raised?
Cue Biopharma has raised $102M across 5 rounds on record. The most recent is an undisclosed round of $30.0M announced in Apr 2026.
When did Cue Biopharma last raise funding?
Cue Biopharma's most recent funding round on record is an undisclosed round of $30.0M, announced in Apr 2026.
Who founded Cue Biopharma?
FundedIQ lists Ronald Seidel (Founder), Usman "oz" (Founder) at Cue Biopharma.
Where is Cue Biopharma headquartered?
Cue Biopharma is based in Cambridge, Massachusetts, United States.
How many employees does Cue Biopharma have?
Cue Biopharma is in the 11-50 employee band.
How does Cue Biopharma's funding compare to other Biotechnology startups?
Cue Biopharma's latest round of $30.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cue Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cue Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.